...
首页> 外文期刊>International Journal of Pharmaceutics >A continuous and highly effective static mixing process for antisolvent precipitation of nanoparticles of poorly water-soluble drugs.
【24h】

A continuous and highly effective static mixing process for antisolvent precipitation of nanoparticles of poorly water-soluble drugs.

机译:一种连续高效的静态混合工艺,用于水溶性差的药物的纳米粒子的反溶剂沉淀。

获取原文
获取原文并翻译 | 示例
           

摘要

Rapid and homogeneous mixing of the solvent and antisolvent is critical to achieve submicron drug particles by antisolvent precipitation technique. This work aims to develop a continuous and highly effective static mixing process for antisolvent precipitation of nanoparticles of poorly water-soluble drugs with spironolactone as a model drug. Continuous antisolvent production of drug nanoparticles was carried out with a SMV DN25 static mixer comprising 6-18 mixing elements. The total flow rate ranged from 1.0 to 3.0 L/min while the flow rate ratio of solvent to antisolvent was maintained at 1:9. It is found that only 6 mixing elements were sufficient to precipitate the particles in the submicron range. Increasing the number of elements would further reduce the precipitated particle size. Increasing flow rate from 1.0 to 3.0 L/min did not further reduce the particle size, while higher drug concentrations led to particle size increase. XRD and SEM results demonstrated that the freshly precipitated drug nanoparticles are in the amorphous state, which would, in presence of the mixture of solvent and antisolvent, change to crystalline form in short time. The lyophilized spironolactone nanoparticles with lactose as lyoprotectant possessed good redispersibility and showed 6.6 and 3.3 times faster dissolution rate than that of lyophilized raw drug formulation in 5 and 10 min, respectively. The developed static mixing process exhibits high potential for continuous and large-scale antisolvent precipitation of submicron drug particles.
机译:溶剂和抗溶剂的快速均匀混合对于通过抗溶剂沉淀技术获得亚微米级药物颗粒至关重要。这项工作旨在开发一种连续高效的静态混合工艺,以螺内酯作为模型药物,对水溶性差的药物的纳米颗粒进行反溶剂沉淀。用包含6-18个混合元件的SMV DN25静态混合器进行药物纳米颗粒的连续反溶剂生产。总流量在1.0至3.0L / min的范围内,而溶剂与反溶剂的流量比保持在1:9。发现只有6个混合元素足以沉淀亚微米范围内的颗粒。增加元素的数量将进一步减小沉淀的粒度。将流速从1.0 L / min增加到3.0 L / min并没有进一步减小粒径,而较高的药物浓度导致粒径增加。 XRD和SEM结果表明,新鲜沉淀的药物纳米颗粒处于无定形状态,在存在溶剂和反溶剂的混合物的情况下,其将在短时间内转变为结晶形式。以乳糖为冻干保护剂的冻干螺内酯纳米颗粒具有良好的再分散性,在5分钟和10分钟内的溶出速率分别比冻干的原料药物制剂快6.6和3.3倍。发达的静态混合工艺在亚微米药物颗粒的连续和大规模反溶剂沉淀方面显示出很高的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号